Strategies to reduce mortality from bacterial sepsis in adults in developing countries

Allen C Cheng, T Eoin West, Direk Limmathurotsakul, Sharon J Peacock, Allen C Cheng, T Eoin West, Direk Limmathurotsakul, Sharon J Peacock

Abstract

Sharon Peacock and colleagues discuss management of adult patients with sepsis in low- and middle-income settings, with a particular emphasis on tropical regions.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1. Mortality and Disability-Adjusted Life Years…
Figure 1. Mortality and Disability-Adjusted Life Years (DALYs) Lost in Adults 15–60 Years Old in 2002 for Three Selected Indicator Diseases, by World Bank Income Level [4]

References

    1. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992;20:864–874. [No authors listed]
    1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, et al. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29:1303–1310.
    1. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348:1546–1554.
    1. World Health Organization. Revised global burden of disease 2002 estimates. 2008. Available: . Accessed 18 July 2008.
    1. Siddiqui S. Not “surviving sepsis” in the developing countries. J Indian Med Assoc. 2007;105:221.
    1. Tanriover MD, Guven GS, Sen D, Unal S, Uzun O. Epidemiology and outcome of sepsis in a tertiary-care hospital in a developing country. Epidemiol Infect. 2006;134:315–322.
    1. Frikha N, Mebazaa M, Mnif L, El Euch N, Abassi M, et al. [Septic shock in a Tunisian intensive care unit: Mortality and predictive factors. 100 cases] Tunis Med. 2005;83:320–325.
    1. Smith C, Arregui LM, Promnitz DA, Feldman C. Septic shock in the Intensive Care Unit, Hillbrow Hospital, Johannesburg. S Afr Med J. 1991;80:181–184.
    1. Degoricija V, Sharma M, Legac A, Gradiser M, Sefer S, et al. Survival analysis of 314 episodes of sepsis in medical intensive care unit in university hospital: Impact of intensive care unit performance and antimicrobial therapy. Croat Med J. 2006;47:385–397.
    1. Silva E, Pedro Mde A, Sogayar AC, Mohovic T, Silva CL, et al. Brazilian Sepsis Epidemiological Study (BASES study) Crit Care. 2004;8:R251–R260.
    1. White NJ. Melioidosis. Lancet. 2003;361:1715–1722.
    1. Currie BJ, Fisher DA, Howard DM, Burrow JN, Lo D, et al. Endemic melioidosis in tropical northern Australia: A 10-year prospective study and review of the literature. Clin Infect Dis. 2000;31:981–986.
    1. Cheng AC, Stephens DP, Anstey NM, Currie BJ. Adjunctive granulocyte colony-stimulating factor for treatment of septic shock due to melioidosis. Clin Infect Dis. 2004;38:32–37.
    1. Chan KP, Low JG, Raghuram J, Fook-Chong SM, Kurup A. Clinical characteristics and outcome of severe melioidosis requiring intensive care. Chest. 2005;128:3674–3678.
    1. Cheng AC, Limmathurotsakul D, Chierakul W, Getchalarat N, Wuthiekanun V, et al. A randomized controlled trial of granulocyte colony-stimulating factor for the treatment of severe sepsis due to melioidosis in Thailand. Clin Infect Dis. 2007;45:308–314.
    1. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008;36:296–327.
    1. Eichacker PQ, Natanson C, Danner RL. Surviving sepsis—Practice guidelines, marketing campaigns, and Eli Lilly. N Engl J Med. 2006;355:1640–1642.
    1. Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;358:125–139.
    1. Sprung CL, Annane D, Keh D, Moreno R, Singer M, et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med. 2008;358:111–124.
    1. World Bank. Country classification. 2008. Available: . Accessed 18 July 2008.
    1. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345:1368–1377.
    1. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34:1589–1596.
    1. Sazawal S, Black RE. Effect of pneumonia case management on mortality in neonates, infants, and preschool children: A meta-analysis of community-based trials. Lancet Infect Dis. 2003;3:547–556.
    1. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med. 2003;29:530–538.
    1. Carroll GC, Snyder JV. Hyperdynamic severe intravascular sepsis depends on fluid administration in cynomolgus monkey. Am J Physiol. 1982;243:R131–R141.
    1. Winslow EJ, Loeb HS, Rahimtoola SH, Kamath S, Gunnar RM. Hemodynamic studies and results of therapy in 50 patients with bacteremic shock. Am J Med. 1973;54:421–432.
    1. Rackow EC, Falk JL, Fein IA, Siegel JS, Packman MI, et al. Fluid resuscitation in circulatory shock: A comparison of the cardiorespiratory effects of albumin, hetastarch, and saline solutions in patients with hypovolemic and septic shock. Crit Care Med. 1983;11:839–850.
    1. Hollenberg SM, Ahrens TS, Annane D, Astiz ME, Chalfin DB, et al. Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update. Crit Care Med. 2004;32:1928–1948.
    1. Hurtado FJ, Nin N. The role of bundles in sepsis care. Crit Care Clin. 2006;22:521–529. x.
    1. Mock C, Visser L, Denno D, Maier R. Aggressive fluid resuscitation and broad spectrum antibiotics decrease mortality from typhoid ileal perforation. Trop Doct. 1995;25:115–117.
    1. Finfer S, Bellomo R, Boyce N, French J, Myburgh J, et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med. 2004;350:2247–2256.
    1. Michell MW, Oliveira HM, Kinsky MP, Vaid SU, Herndon DN, et al. Enteral resuscitation of burn shock using World Health Organization oral rehydration solution: A potential solution for mass casualty care. J Burn Care Res. 2006;27:819–825.
    1. Nager AL, Wang VJ. Comparison of nasogastric and intravenous methods of rehydration in pediatric patients with acute dehydration. Pediatrics. 2002;109:566–572.
    1. Parrillo JE, Parker MM, Natanson C, Suffredini AF, Danner RL, et al. Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med. 1990;113:227–242.
    1. Weippl G. [Infectious toxic hypotension—Effect and dosage of midodrine (author's transl)] Padiatr Padol. 1979;14:211–216.
    1. Carlbom DJ, Rubenfeld GD. Barriers to implementing protocol-based sepsis resuscitation in the emergency department—Results of a national survey. Crit Care Med. 2007;35:2525–2532.
    1. Harbarth S, Garbino J, Pugin J, Romand JA, Lew D, et al. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med. 2003;115:529–535.
    1. Berkley JA, Lowe BS, Mwangi I, Williams T, Bauni E, et al. Bacteremia among children admitted to a rural hospital in Kenya. N Engl J Med. 2005;352:39–47.
    1. Murdoch DR, Woods CW, Zimmerman MD, Dull PM, Belbase RH, et al. The etiology of febrile illness in adults presenting to Patan hospital in Kathmandu, Nepal. Am J Trop Med Hyg. 2004;70:670–675.
    1. Chaowagul W, White NJ, Dance DA, Wattanagoon Y, Naigowit P, et al. Melioidosis: A major cause of community-acquired septicemia in northeastern Thailand. J Infect Dis. 1989;159:890–899.
    1. Suttinont C, Losuwanaluk K, Niwatayakul K, Hoontrakul S, Intaranongpai W, et al. Causes of acute, undifferentiated, febrile illness in rural Thailand: Results of a prospective observational study. Ann Trop Med Parasitol. 2006;100:363–370.
    1. Phetsouvanh R, Phongmany S, Soukaloun D, Rasachak B, Soukhaseum V, et al. Causes of community-acquired bacteremia and patterns of antimicrobial resistance in Vientiane, Laos. Am J Trop Med Hyg. 2006;75:978–985.
    1. Archibald LK, Reller LB. Clinical microbiology in developing countries. Emerg Infect Dis. 2001;7:302–305.
    1. Petti CA, Polage CR, Quinn TC, Ronald AR, Sande MA. Laboratory medicine in Africa: A barrier to effective health care. Clin Infect Dis. 2006;42:377–382.
    1. Punyagupta S. Melioidosis. Review of 686 cases and presentation of a new clinical classification. In: Punyagupta S, Sirisanthana T, Stapatayavong B, . Melioidosis. Bangkok: Bangkok Medical Publisher; 1989. pp. 217–229. editors.
    1. White NJ, Dance DA, Chaowagul W, Wattanagoon Y, Wuthiekanun V, et al. Halving of mortality of severe melioidosis by ceftazidime. Lancet. 1989;2:697–701.
    1. Parry CM, Ho VA, Phuong le T, Bay PV, Lanh MN, et al. Randomized controlled comparison of ofloxacin, azithromycin, and an ofloxacin-azithromycin combination for treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever. Antimicrob Agents Chemother. 2007;51:819–825.
    1. Kamolratanakul P, Dhanamun B, Thaithong S. Human behavior in relation to selection of malaria treatment. Southeast Asian J Trop Med Public Health. 1992;23:189–194.
    1. Thamlikitkul V. Antibiotic dispensing by drug store personnel in Bangkok, Thailand. J Antimicrob Chemother. 1988;21:125–131.
    1. Wertheimer AI, Chaney NM, Santella T. Counterfeit pharmaceuticals: Current status and future projections. J Am Pharm Assoc. 2003;43:710–717. 717–718. quiz.
    1. De Stefano V, Chiusolo P, Paciaroni K, Leone G. Epidemiology of factor V Leiden: Clinical implications. Semin Thromb Hemost. 1998;24:367–379.
    1. Nandi P, Wong KP, Wei WI, Ngan H, Ong GB. Incidence of postoperative deep vein thrombosis in Hong Kong Chinese. Br J Surg. 1980;67:251–253.
    1. Lee HM, Suk KS, Moon SH, Kim DJ, Wang JM, et al. Deep vein thrombosis after major spinal surgery: Incidence in an East Asian population. Spine. 2000;25:1827–1830.
    1. Chotanaphuti T, Ongnamthip P, Silpipat S, Foojareonyos T, Roschan S, et al. The prevalence of thrombophilia and venous thromboembolism in total knee arthroplasty. J Med Assoc Thai. 2007;90:1342–1347.
    1. Mannucci PM. Thrombosis and bleeding disorders outside Western countries. J Thromb Haemost. 2007;5(Suppl 1):68–72.
    1. Pepe PE, Potkin RT, Reus DH, Hudson LD, Carrico CJ. Clinical predictors of the adult respiratory distress syndrome. Am J Surg. 1982;144:124–130.
    1. Hudson LD, Milberg JA, Anardi D, Maunder RJ. Clinical risks for development of the acute respiratory distress syndrome. Am J Respir Crit Care Med. 1995;151:293–301.
    1. Leong JR, Huang DT. Ventilator-associated pneumonia. Surg Clin North Am. 2006;86:1409–1429.
    1. Jaimes F, De La Rosa G, Gomez E, Munera P, Ramirez J, et al. Incidence and risk factors for ventilator-associated pneumonia in a developing country: Where is the difference. Respir Med. 2007;101:762–767.
    1. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med. 2000;342:1301–1308. [No authors listed]
    1. Hussain SF, Haqqee R, Iqbal J. Non-invasive ventilation in the management of acute respiratory failure in Pakistan. Trop Doct. 2004;34:238–239.
    1. George IA, John G, John P, Peter JV, Christopher S. An evaluation of the role of noninvasive positive pressure ventilation in the management of acute respiratory failure in a developing country. Indian J Med Sci. 2007;61:495–504.
    1. Phu NH, Hien TT, Mai NT, Chau TT, Chuong LV, et al. Hemofiltration and peritoneal dialysis in infection-associated acute renal failure in Vietnam. N Engl J Med. 2002;347:895–902.
    1. Maitland K, Akech S, Gwer S, Idro R, Fegan G, et al. Phase III trials required to resolve clinical equipoise over optimal fluid management in children with severe malaria. PLoS Clin Trials. 2007;2:e2. doi: .
    1. Idro R, Aketch S, Gwer S, Newton CR, Maitland K. Research priorities in the management of severe Plasmodium falciparum malaria in children. Ann Trop Med Parasitol. 2006;100:95–108.
    1. Punjabi NH, Hoffman SL, Edman DC, Sukri N, Laughlin LW, et al. Treatment of severe typhoid fever in children with high dose dexamethasone. Pediatr Infect Dis J. 1988;7:598–600.
    1. Rogerson SJ, Spooner VJ, Smith TA, Richens J. Hydrocortisone in chloramphenicol-treated severe typhoid fever in Papua New Guinea. Trans R Soc Trop Med Hyg. 1991;85:113–116.
    1. Hoffman SL, Punjabi NH, Kumala S, Moechtar MA, Pulungsih SP, et al. Reduction of mortality in chloramphenicol-treated severe typhoid fever by high-dose dexamethasone. N Engl J Med. 1984;310:82–88.
    1. Annane D, Sebille V, Charpentier C, Bollaert PE, Francois B, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA. 2002;288:862–871.
    1. Preiser J. Intensive glycemic control in med-surg patients (European Glucontrol trial) 2007. Society of Critical Care Medicine 36th Critical Care Congress; 17–21 February 2007; Orlando, Florida, United States.
    1. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001;344:699–709.
    1. Abraham E, Laterre PF, Garg R, Levy H, Talwar D, et al. Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. N Engl J Med. 2005;353:1332–1341.
    1. Gove S. Integrated management of childhood illness by outpatient health workers: Technical basis and overview. The WHO Working Group on Guidelines for Integrated Management of the Sick Child. Bull World Health Organ. 1997;75(Suppl 1):7–24.
    1. Duke T, Kelly J, Weber M, English M, Campbell H. Hospital care for children in developing countries: Clinical guidelines and the need for evidence. J Trop Peds. 2006;52:1–2.
    1. Topley JM, Nkrumah FK. Paediatric intensive care in Harare. Ann Trop Paediatr. 1987;7:282–286.
    1. Musgrove P. Public spending on health care: How are different criteria related. Health Policy. 1999;47:207–223.
    1. Bhagwanjee S. Critical care in Africa. Crit Care Clin. 2006;22:433–438. viii.
    1. Phraisuwan P, Whitney EA, Tharmaphornpilas P, Guharat S, Thongkamsamut S, et al. Leptospirosis: Skin wounds and control strategies, Thailand, 1999. Emerg Infect Dis. 2002;8:1455–1459.
    1. Snow RW, Gouws E, Omumbo J, Rapuoda B, Craig MH, et al. Models to predict the intensity of Plasmodium falciparum transmission: Applications to the burden of disease in Kenya. Trans R Soc Trop Med Hyg. 1998;92:601–606.
    1. Matsuda F, Ishimura S, Wagatsuma Y, Higashi T, Hayashi T, et al. Prediction of epidemic cholera due to Vibrio cholerae O1 in children younger than 10 years using climate data in Bangladesh. Epidemiol Infect. 2008;136:73–79.
    1. Ali M, Wagatsuma Y, Emch M, Breiman RF. Use of a geographic information system for defining spatial risk for dengue transmission in Bangladesh: Role for Aedes albopictus in an urban outbreak. Am J Trop Med Hyg. 2003;69:634–640.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir